testosterone deficiency (TD) therapy if prostate cancer
Last edited 05/2018
Testosterone therapy and prostate cancer
Testosterone therapy can be offered to men with symptomatic TD and treated localised low-risk prostate cancer (Gleason score <8, stages 1-2, preoperative prostate specific antigen (PSA) <10ng/mL), as long as it is not started before 1 year of follow-up and they have no evidence of active disease (based on measured PSA level, DRE result and absence of metastases).
Reference: